HCPLive Network
PRACTICE MANAGEMENT

Roundtable: To Sell or Not to Sell, Part III

| Friday, November 15, 2013
Moderator:
Lee Ferber, CFP
Marcus Gettry, CPA, P.C.
David Mandell
OJM Group, LLC
Principal
Todd Rodriguez
Fox Rothschild
Partner, Health Law Practice


In this roundtable, panelists will discuss analyzing whether a practice should stay private or sell to a hospital and Todd Rodriguez, partner with Fox Rothschild, explained specific terms embedded in hospital employment agreements. He looks specifically for things, such as grounds for termination and productivity targets, in the contract that might be beyond the control of the physician
 
In particular, he views the most important part of the contract for physicians who are leaving private practice is the ability to return to private practice.
 
“If you get into the arrangement and decide it’s not your cup of tea or it’s not working out for whatever reason, you at least can go back to the status quo,” Rodriguez said. “That’s a fairly big protection.”



Part 1 | Part 2 | Part 4 | Part 5

RELATED ARTICLES
While Wall Street is often viewed as the center of the investment universe, a far less exciting – but potentially more powerful – environment exists in the halls of academia. In this environment, professors at schools like Wharton, Yale, MIT, Stanford and the University of Chicago examine decades of financial data in search of patterns and explanatory variables.
Many investors are still shy from the drubbing they took in 2008 or feel that it's too late to get into the market now. That kind of scared thinking is going to cost them.
The 401(k) retirement accounts of many employees are going up in smoke due to excessive fees charged by their investment company. Unless this can be rectified through legislation, higher earners may end up paying for the shortfall later.
RECENT CLINICAL ARTICLES
The start of the fall season means that around the country children are settling into their school routines. It also means cold and flu season is just around the corner, and with a particularly harsh winter predicted for parts of the country that could mean bad news for the end of 2014.
Adding the drug pertuzumab (Perjeta) to trastuzumab may give women with human epidermal growth factor receptor 2-positive metastatic breast cancer a boost in survival, according to new research presented Sunday at the annual meeting of the European Society of Medical Oncology, held from Sept. 26 to 29 in Madrid.
Obesity and inflammation in late adolescence are associated with increased risk for colon and rectal cancer in adulthood, according to a study presented at the American Association for Cancer Research's International Conference on Frontiers in Cancer Prevention Research, held from Sept. 28 to Oct. 1 in New Orleans.